Skip to content

Checked

Xencor Inc

Nasdaq: XNCR · Pharmaceutical Preparations · Pasadena, CA

Revenue
$125.6M
+13.7% vs. prior year
Net income
-$91.92M
-73.2% net margin
Total assets
$875.5M
Diluted EPS
-$1.24

Company details

As reported to the SEC

SEC CIK
1326732
Stock
Nasdaq: XNCR
Legal Entity Identifier (LEI)
549300V5IF65437JKG30
Headquarters
465 N. Halstead St., Suite 200, Pasadena, CA 91107
Incorporated in
Delaware
Fiscal year end (SEC record)
December 31
Filer status
Accelerated filer
Phone
(626) 305-5900
Employer ID (EIN)
20-1622502
Last annual report
02/25/2026
Last quarterly report
08/05/2026

Annual financials

U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.

Fiscal year ended12/31/202512/31/202412/31/202312/31/202212/31/2021
Revenue$125.6M$110.5M$174.6M$164.6M$275.1M
Operating income-$177.5M-$178.4M-$132.4M-$82.47M$43.77M
Net income-$91.92M-$232.6M-$133.1M-$55.18M$82.63M
Diluted earnings per share-$1.24-$3.58-$2.20-$0.93$1.37
Research and development$239.4M$227.7M$253.6M$199.6M$192.5M
Total assets$875.5M$951.9M$965.1M$846.3M$838.2M
Total liabilities$239.9M$277.9M$303M$118.8M$104.7M
Shareholders' equity$635.6M$677.6M$661.8M$727.5M$733.5M
Cash and cash equivalents$54.07M$40.88M$53.79M$53.94M$143.5M
Long-term debt$76.48M$115.2M$161.8M$0Not reported
Cash from operations-$135.1M-$202.2M-$77.93M$24.48M-$16.85M
Capital expenditures$3.15M$6.1M$18.45M$38.49M$13.3M
Revenue by fiscal year
$122.7M
$275.1M
$164.6M
$174.6M
$110.5M
$125.6M

Federal and state records filed under the name Xencor Inc

Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.

Work visa sponsorship

Certified H-1B and PERM green card filings with the Department of Labor

Employer on filingH-1BPERM
Xencor, Inc.Pasadena, CA11

Recent filings

60 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here

All filings

Swipe the table sideways to see more columns.

43 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Xencor Inc in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.

Other pharmaceutical preparations

All in this industry

Swipe the table sideways to see more columns.

CompanyHeadquartersRevenueNet income
Johnson & JohnsonJNJNew Brunswick, NJ$94.19B$26.8B
Eli Lilly & CoLLYIndianapolis, IN$65.18B$20.64B
Merck & Co., Inc.MRKRahway, NJ$65.01B$18.25B
Pfizer IncPFENew York, NY$62.58B$7.77B
AbbVie Inc.ABBVNorth Chicago, IL$61.16B$4.23B
Astrazeneca PLCAZNCambridge, United Kingdom$58.74B$10.22B
Bristol Myers Squibb CoBMYPrinceton, NJ$48.19B$7.05B
Abbott LaboratoriesABTAbbott Park, IL$44.33B$6.52B

Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.

Frequently asked questions

What is Xencor Inc's CIK number?
Xencor Inc's SEC Central Index Key (CIK) is 1326732.
What is Xencor Inc's stock ticker?
Xencor Inc trades as Nasdaq: XNCR.
What was Xencor Inc's revenue?
Xencor Inc reported revenue of $125.6M for the fiscal year ended Dec 31, 2025, +13.7% from the year before.
When does Xencor Inc's fiscal year end?
Xencor Inc's fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
Where is Xencor Inc headquartered?
Xencor Inc's principal executive office on file with the SEC is in Pasadena, CA.
Does Xencor Inc sponsor H-1B visas?
Department of Labor records show 1 certified H-1B filings and 1 certified PERM filings under the name Xencor Inc.

Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026